Skip to main content
Log in

Pharmacokinetic and pharmacodynamic studies following the intravenous and oral administration of the antiparkinsonian drug biperiden to normal subjects

  • Short Communications
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The pharmacokinetics and pharmacodynamics (changes in pupil size and salivary flow) of biperiden following a single oral and intravenous dose were investigated in six normal subjects.

After the injection plasma concentrations declined biphasically, with half-times of 1.5 h for the rapid phase and 24 h for the terminal phase. Clearance and apparent volume of distribution were high (12 ml·min−1·kg−1 and 24 l·kg−1 respectively). Absorption was rapid but the systemic availability was incomplete (33%), probably due to first-pass metabolism.

Central nervous system (CNS) adverse effects and changes in pupil size were observed after both routes of administration while salivary flow was affected only by the injection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Le Bris Th, Brode E (1985) Capillary gas-chromatographic determination of biperiden in human plasma. Drug Res 35: 149–151

    Google Scholar 

  2. Hollmann M, Brode E, Greger G, Müller-Peltzer M, Wetzelsberger N (1984) Biperiden effects and plasma levels in volunteers. Eur J Clin Pharmacol 27: 619–621

    Google Scholar 

  3. Trimarchi E, Gelmi C, Bianchi PE (1978) Metodica fotografica per la valutazione della farmacodiagnostica pupillare. Minerva Oftalmol 20: 173–176

    Google Scholar 

  4. Perucca E, Albrici A, Gatti G, Spalluto R, Visconti M, Crema A (1984) Pharmacokinetics of oxiracetam following intravenous and oral administration in healthy volunteers. Eur J Drug Metab Pharmacokinet 9: 267–274

    Google Scholar 

  5. Stock B, Spiteller G (1979) Der Metabolismus von Antiparkinson-Mitteln. Drug Res 29: 610–615

    Google Scholar 

  6. Perucca E, Richens A (1979) Reduction of oral availability of lignocaine by induction of first-pass metabolism in epileptic patients. Br J Clin Pharmacol 8: 21–31

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grimaldi, R., Perucca, E., Ruberto, G. et al. Pharmacokinetic and pharmacodynamic studies following the intravenous and oral administration of the antiparkinsonian drug biperiden to normal subjects. Eur J Clin Pharmacol 29, 735–737 (1986). https://doi.org/10.1007/BF00615970

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00615970

Key words

Navigation